Stock NIDAN NIDAN LABORATORIES AND HEALTHCARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Nidan Laboratories and Healthcare Limited

Equities

NIDAN

INE0J6L01013

Healthcare Facilities & Services

Market Closed - NSE India S.E.
Other stock markets
 12:43:55 04/07/2024 BST 		5-day change 1st Jan Change
36.95 INR -1.60% Intraday chart for Nidan Laboratories and Healthcare Limited +2.35% +10.96%
05-23 Nidan Laboratories and Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
02-22 Nidan Laboratories and Healthcare Limited Appoints Kunika Maheshwari as Company Secretary, with Effect from 1 March 2024 CI

Valuation

Fiscal Period: March 2022 2023
Capitalization 1 461.5 470.5
Enterprise Value (EV) 1 573.4 495.6
P/E ratio 14.3 x 13.3 x
Yield - -
Capitalization / Revenue 1.56 x 1.94 x
EV / Revenue 1.93 x 2.04 x
EV / EBITDA 6.1 x 7.3 x
EV / FCF 10,445,419 x 5,722,616 x
FCF Yield 0% 0%
Price to Book 0.66 x 0.68 x
Nbr of stocks (in thousands) 13,900 13,900
Reference price 2 33.20 33.85
Announcement Date 11/08/23 11/08/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023
Net sales 1 206.1 221.8 207.9 296.6 242.7
EBITDA 1 78.45 76.36 88.87 94.06 67.9
EBIT 1 46.09 44.48 57.02 67.83 37.05
Operating Margin 22.37% 20.05% 27.43% 22.87% 15.27%
Earnings before Tax (EBT) 1 2.235 7.146 33.02 45.2 48.12
Net income 1 2.235 7.146 23.02 26.63 35.4
Net margin 1.08% 3.22% 11.07% 8.98% 14.59%
EPS 2 0.2258 0.7218 2.326 2.320 2.546
Free Cash Flow - 5.933 -30.66 54.9 86.61
FCF margin - 2.67% -14.74% 18.51% 35.69%
FCF Conversion (EBITDA) - 7.77% - 58.36% 127.56%
FCF Conversion (Net income) - 83.03% - 206.15% 244.68%
Dividend per Share - - - - -
Announcement Date 08/10/21 08/10/21 08/10/21 11/08/23 11/08/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023
Net Debt 1 278 270 291 112 25.1
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) 3.547 x 3.53 x 3.275 x 1.19 x 0.3698 x
Free Cash Flow - 5.93 -30.7 54.9 86.6
ROE (net income / shareholders' equity) - 6.7% 18.9% 6.72% 5.23%
ROA (Net income/ Total Assets) - 6.3% 7.3% 6.02% 2.68%
Assets 1 - 113.4 315.4 442.6 1,321
Book Value Per Share 2 10.40 11.10 13.50 50.60 50.00
Cash Flow per Share 2 4.390 7.470 7.370 6.220 6.060
Capex - 0.09 32.4 70.7 6.68
Capex / Sales - 0.04% 15.6% 23.85% 2.75%
Announcement Date 08/10/21 08/10/21 08/10/21 11/08/23 11/08/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
NIDAN LABORATORIES AND HEALTHCARE LIMITED Stock Nidan Laboratories and Healthcare Limited
+10.96% 6.25M
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-19.73% 8.22B
RADNET, INC. Stock RadNet, Inc.
+70.43% 4.38B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
+12.76% 2.81B
SYNLAB AG Stock SYNLAB AG
-2.28% 2.66B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-15.14% 1.75B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-58.41% 1.74B
FLEURY S.A. Stock Fleury S.A.
-16.63% 1.47B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+24.33% 1.24B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-50.73% 1.03B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. NIDAN Stock
  4. Financials Nidan Laboratories and Healthcare Limited